Inequalities in financial burden of tuberculosis among affected families across 19 low- and middle-income countries

Tuberculosis (TB) remains a major global public health problem, with majority of the cases occurring in low- and middle-income countries (LMICs). Despite its growing burden, cross-country evidence on inequalities in financial burden among affected families is limited. This study aims to assess catastrophic costs and related inequalities across 19 LMICs. The study employed a cross-country analysis of 19 national TB Patient Cost Surveys data extracted from the WHO Health Equity Assessment Toolkit (HEAT) online software. The main outcome was the percentage of families affected by TB facing catastrophic costs due to TB. Inequalities were assessed by drug resistance status, comparing drug-susceptible TB (DS-TB) and drug-resistant TB (DR-TB), using four summary measures: Difference (D), Ratio (R), Population Attributable Risk (PAR), and Population Attributable Fraction (PAF). No inferential statistics were done beyond the descriptive phase. The average percentage of TB-affected families experiencing catastrophic costs due to TB ranged from 19.2% in Lesotho to 80% in Zimbabwe. In 10 of the 19 countries, over half of TB-affected families faced catastrophic costs. When disaggregated, all countries reported higher catastrophic costs among DR-TB-affected families, except Burkina Faso. The absolute difference (D) between DR-TB and DS-TB ranged from –4% in Burkina Faso to 74.8% in Lesotho. The highest disparities were in Lesotho (D = 74.8%), Kenya (D = 60%), and Papua New Guinea (D = 51%). Ratio showed DR-TB families were up to 5.3 times more likely to experience catastrophic costs in Lesotho, with high ratios also in Kenya (3.3) and Thailand (2.6). All PAR and PAF values were negative, indicating that reducing the financial burden on DR-TB families to the level of DS-TB families could significantly lower the overall rate of catastrophic costs. The greatest potential gains were observed in Mongolia (PAR = 6%), DRC (PAR = 5%), and Brazil (PAR = 3.7%). The study showed substantial inequalities in the financial burden of TB on families across 19 LMICs, with DR-TB-affected families facing higher risks of catastrophic health cost than DS-TB families. There is an urgent need for targeted financial protection interventions, integrated within broader UHC strategies, to ensure that no TB-affected family is left behind

Descriptive statistics · Equity (law) · Global health · Health care · Inequality · Population · Public health · Tuberculosis · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Tuberculosis Research and Epidemiology

• Financial burden for tuberculosis patients in low- and middle-income countries

  Tadayuki Tanimura, Ernesto Jaramillo et al.•European Respiratory Journal•2014

  Incluir item

• The catastrophic cost of TB care

  Open Access•Olivia Alise D’Silva, Samantha Lancione et al.•PLOS Global Public Health•2025

  Incluir item

• Households experiencing catastrophic costs due to tuberculosis in Uganda

  Open Access•Winters Muttamba, Racheal Tumwebaze et al.•BMC Public Health•2020

  Incluir item

• Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990–2021

  Open Access•Huafei Yang, Xinyi Ruan et al.•BMC Public Health•2024

  Incluir item

• Modelling the impact of social protection on tuberculosis

  Open Access•Delia Boccia, William E Rudgard et al.•BMC Public Health•2018

  Incluir item

• The economic burden of TB diagnosis and treatment in South Africa

  Open Access•Nicola Foster, Anna Vassall et al.•Social Science & Medicine•2015

  Incluir item